0001493152-23-027577.txt : 20230810
0001493152-23-027577.hdr.sgml : 20230810
20230810163028
ACCESSION NUMBER: 0001493152-23-027577
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230808
FILED AS OF DATE: 20230810
DATE AS OF CHANGE: 20230810
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DUNTON ALAN W
CENTRAL INDEX KEY: 0001304773
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32188
FILM NUMBER: 231160036
MAIL ADDRESS:
STREET 1: VICURON PHARMACEUTICALS INC
STREET 2: 455 S GULPH ROAD SUITE 305
CITY: KING OF PRUSSIA
STATE: PA
ZIP: 19406
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ORAGENICS INC
CENTRAL INDEX KEY: 0001174940
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 593410522
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4902 EISENHOWER BLVD
STREET 2: SUITE 125
CITY: TAMPA
STATE: FL
ZIP: 33634
BUSINESS PHONE: 8132867900
MAIL ADDRESS:
STREET 1: 4902 EISENHOWER BLVD
STREET 2: SUITE 125
CITY: TAMPA
STATE: FL
ZIP: 33634
4
1
ownership.xml
X0508
4
2023-08-08
0
0001174940
ORAGENICS INC
OGEN
0001304773
DUNTON ALAN W
4902 EISENHOWER BOULEVARD
TAMPA
FL
33634
1
0
0
0
0
Common Stock
2023-08-08
4
A
0
25000
0
A
25689
D
Represents an award of restricted stock pursuant to the Company's non-employee director compensation program under the Company's 2021 Equity Incentive Plan with 20,000 shares vesting immediately and 5,000 shares vesting in six (6) months.
Reflects adjustments made in connection with the 1-for-60 reverse stock split of the Issuer's common stock which became effective on January 23, 2023
/s/ Mark A. Catchur, as Attorney-in-Fact for Alan W. Dunton
2023-08-10